Octant Biotech
Phase 1/2Octant merges next-generation biology, chemistry, and computation to engineer precision medicines that push past the boundaries of traditional drug discovery.
Founded
2018
Focus
Small Molecules
About
Octant merges next-generation biology, chemistry, and computation to engineer precision medicines that push past the boundaries of traditional drug discovery.
Funding History
3Total raised: $125M
Series B$80MCatalio Capital ManagementJul 15, 2023
Series A$35MAndreessen HorowitzOct 15, 2021
Seed$10MAndreessen HorowitzMay 15, 2019
Company Info
TypePrivate
Founded2018
LocationEmeryville, United States
StagePhase 1/2
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile